Opinion piece by Anders Bjarklev, President of DTU - Brian Mikkelsen, CEO of Danish Chamber of Commerce - Kristian Jensen, CEO of Green Power Denmark ...
Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results